|
GV20-0251 Clinical Trials
3 actively recruiting trials across 1 location
Pipeline
Phase 1: 1Phase 1/2: 2
Top Sponsors
- GV20 Therapeutics2
- West China Hospital1
Indications
- Lung Cancer3
- Cancer3
- Liver Disease2
- pMMR/MSS Adenocarcinoma of the Colon or Rectum2
- Squamous Head and Neck Carcinoma2
Other2 trials
Los Angeles, California1 trial
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
The Angeles Clinic and Research Institute
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.